Comorbidities Up Other-Cause Mortality for Men With Prostate Cancer

Share this content:
Comorbidities Up Other-Cause Death for Men With Prostate CA
Comorbidities Up Other-Cause Death for Men With Prostate CA

(HealthDay News) -- Among men with nonmetastatic prostate cancer, the risk for other-cause mortality increases with the number of comorbid conditions, particularly in older men, according to a study published online May 20 in the Annals of Internal Medicine.

Timothy J. Daskivich, M.D., from the University of California in Los Angeles, and colleagues examined the effect of age, comorbidity, and tumor risk on prostate cancer-specific and other-cause mortality using data from a nationally representative cohort of 3,183 men with nonmetastatic prostate cancer at diagnosis.

The researchers found that for men with none, one, two, and three or more comorbid conditions, the 14-year cumulative other-cause mortality rates were 24%, 33%, 46%, and 57%, respectively. Subhazard ratios for other-cause mortality were 1.2, 2.0, and 2.6, respectively, among men diagnosed at age 65 years with one, two, and three or more comorbid conditions (versus none).

For those with three or more comorbid conditions aged 60 years or younger, 61 to 74 years, and 75 years or older at diagnosis, 10-year other-cause mortality rates were 26%, 40%, and 71%, respectively. For patients with low-risk and intermediate-risk disease, prostate cancer-specific mortality was minimal (3% and 7%, respectively), but was appreciable for those with high-risk disease (18%). Prostate-cancer specific mortality did not vary by number of comorbid conditions (10% to 11% in all groups).

"Older men with multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this information when deciding between conservative management and aggressive treatment for low- or intermediate-risk prostate cancer," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs